News

Opinion
Zacks Investment Research on MSN3hOpinion
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...
The medication finasteride has become popular among young men. But for those struggling to conceive, it could be the reason.
A former United Airlines captain has filed a federal lawsuit in the U.S. District Court for the Northern District of Illinois ...
On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
The Sporting News tracked live scoring updates and highlights for Taylor Fritz vs. Carlos Alcaraz in the 2025 Wimbledon men's singles semifinals. Here are complete results from the tennis Grand Slam.
Mr Richard Delali Ahedor, the National President of the Ghana Health Information Management Association (GHIMA), has raised concern over ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...